In this current study, we conducted co-immunoprecipitation (Co-IP) and found that KRT19 interacts with β-catenin alone in colon cancer cells and with the β-catenin/RAC1 complex in breast cancer cells (Figure 5c). Here, RAC1 is linked to malignant colon neoplasm.